Early diagnosis of inherited metabolic diseases: towards improving outcome Erik HarmsAdelbert RoscherSylvia Stöckler-Ipsiroglu Preface 11 November 2003 Pages: S1 - S1
Arguments for early screening: a clinician’s perspective John H. Walter Article 29 November 2003 Pages: S2 - S4
Health economic issues of screening programmes Manfred Wildner Article 01 November 2003 Pages: S5 - S7
Criteria for decision-making – what makes sense? Bernd Richter Article 30 October 2003 Pages: S8 - S12
Technology challenges in screening single gene disorders Andreas BraunRichard RothMatthew J. McGinniss Article 23 October 2003 Pages: S13 - S16
Glutaric aciduria type 1 and neonatal screening: time to proceed—with caution Andrea Superti-Furga Article 25 October 2003 Pages: S17 - S20
The impact of screening for propionic and methylmalonic acidaemia James V. LeonardSuresh VijayaraghavanJohn H. Walter Article 30 October 2003 Pages: S21 - S24
Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: evaluating the effects on outcome Carol Dezateux Article 20 November 2003 Pages: S25 - S28
Long-term outcome of patients with urea cycle disorders and the question of neonatal screening Claude Bachmann Article 21 November 2003 Pages: S29 - S33
Lysosomal storage disorders: emerging therapeutic options require early diagnosis Peter J. MeikleJohn J. Hopwood Article 11 November 2003 Pages: S34 - S37
Early oral cysteamine therapy for nephropathic cystinosis William A. Gahl Article 11 November 2003 Pages: S38 - S41
Screening for cystic fibrosis: the practice and the debate James R. BonhamMelanie DowningAnn Dalton Article 14 November 2003 Pages: S42 - S45
Molecular characterisation and neuropsychological outcome of 21 patients with profound biotinidase deficiency detected by newborn screening and family studies Dorothea MöslingerAdolf MühlSylvia Stöckler-Ipsiroglu Article 20 November 2003 Pages: S46 - S49
Early diagnosis of inherited metabolic disorders towards improving outcome: the controversial issue of galactosaemia Susanne Schweitzer-Krantz Article 12 November 2003 Pages: S50 - S53
Quality control requirements in neonatal screening Toni Torresani Article 28 November 2003 Pages: S54 - S56
Data required for the evaluation of newborn screening programmes Bernhard LieblUta Nennstiel-RatzelRüdiger von Kries Article 13 November 2003 Pages: S57 - S61
Ethical issues in newborn screening and the impact of new technologies Bridget Wilcken Article 14 November 2003 Pages: S62 - S66
Advances in analytical mass spectrometry to improve screening for inherited metabolic diseases Wulf RöschingerBernhard OlgemöllerAdelbert A. Roscher Article 14 November 2003 Pages: S67 - S76